TP53 and cancer: Among human cancers, TP53 is the most frequently mutated gene, and TCGA data has shown that p53 ‘gain-of-functions’ mutants bind to, and upregulate, several chromatin regulatory genes including the methyltransferases MLL1 – also known as KMT2A – which is highly prevalent in our cohort (31%) [34].